Heterocyclic compounds as kinase inhibitors

Heterocyclic compounds as CDK4 or CDK6 or other CDK inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology.

Saved in:
Bibliographic Details
Main Authors CHEN, Jiyun, PHAM, Son Minh, GANGAR, Mukesh, KANKANALA, Jayakanth, BHATT, Bhawana, SHETE, Amit S, CHAKRAVARTY, Sarvajit, PUJALA, Brahmam
Format Patent
LanguageEnglish
Published 10.03.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:Heterocyclic compounds as CDK4 or CDK6 or other CDK inhibitors are provided. The compounds may find use as therapeutic agents for the treatment of diseases and may find particular use in oncology.
Bibliography:Application Number: AU20200329288